"new research facility in the Bay Area that will focus on the discovery and development of new drugs focused on diseases related to aging, with a spotlight on neurodegeneration and cancer"
"While cancer has been a hot R&D field for some years now, neurodegeneration has proved to be a radically different story. Attempts to develop a new drug for Alzheimer's, one of the biggest targets in that field, have been running a 99% failure rate, with some expensive programs failing badly in Phase III. Analysts agree on one thing, though. Any company which can develop an effective therapy for the ailment will be able to cash in the industry's biggest lottery ticket"
Google co-founder Sergey Brin has revealed that he has a 50% chance of developing Parkinson's disease. He's already donated hundreds of millions to Parkinson's research.
BLT Price at posting:
$1.03 Sentiment: Hold Disclosure: Held
